Dow licenses NRC’s pathogen-fighting technology

Dow AgroSciences has obtained worldwide licensing rights from the National Research Council (NRC) to market technologies that reduce the risk of food-borne pathogens. The agreement gives the company exclusive rights to specific antibody technologies that are being developed under a 2001 collaborative agreement between Dow AgroSciences Canada and NRC’s Institute for Biological Sciences in Ottawa. The company says the collaboration has already developed inventions that hold great promise in combating two of the most common food-related health threats, E coli O157:H7 in cattle and Campylobacter jejuni in poultry.